For research-intensive organizations, COVID-19 and our collective awakening to the insidious realities of racism have exposed the limitations of accepted approaches to inclusion, diversity, equity and accessibility.
COVID-19 and the Future of Health Research and Innovation: Roundtable Report & Recording
We convened a virtual roundtable in collaboration with Life Sciences Ontario (LSO), featuring a diverse panel of leaders, on what COVID-19 is teaching us and how we can prepare our health research and innovation ecosystem for a resilient, productive and impactful future.
COVID-19 and the Future of Health Research and Innovation
We argue that the pandemic represents an inflection point for the health research and innovation system. There has never been greater recognition that “science is the solution”. There has never been a more fertile moment to reinvigorate investment in health research and innovation and create the best system possible.
How ready is Canada for personalized healthcare?
On February 6th, 2020, Shift Health facilitated a half-day workshop with over 100 stakeholders, including patients, healthcare providers, government, industry and researchers.
Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease
Shift Health has led a study showing that we are systematically underestimating the global socioeconomic burden of Alzheimer’s disease. The hidden costs have important implications for policymakers.
From the Voices of People with Haemophilia A and Their Caregivers
A Shift Health study shows that available treatments for people living with haemophilia A impact psychological wellbeing, employment opportunities and adherence to treatment regimens, helping to inform decision‐making around the value innovative treatments.
Driven by emerging clinical evidence and increasingly favourable regulatory conditions, companies are racing to develop cannabis-based pharmaceuticals for diverse indications. In this paper, we explore three trends that we believe will critically shape the cannabis industry over the coming years.
Product Development 101
Shift Health partnered with the Global HIV Vaccine Enterprise to pilot a two-day Boot Camp aimed at educating vaccine development partners across sectors—academia, government, funders, NGOs, industry—on strategies, tools and best practices enabling product development.
Advancing the Development of an HIV Vaccine for South Africa and Beyond
The Pox-Protein Public-Private Partnership (P5)—has enlisted Shift Health to help advance priorities and achieve several partnership goals over the course of a multi-year product development plan